Nicholson Wealth Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
5,858
-134
-2% -$45.9K 1.25% 26
2026
Q1
$2.11M Sell
5,992
-27
-0.4% -$9.63K 1.23% 24
2025
Q4
$1.97M Sell
6,019
-171
-3% -$54.2K 1.16% 23
2025
Q3
$1.75M Buy
6,190
+272
+5% +$78.9K 1.02% 43
2025
Q2
$1.65M Buy
5,918
+35
+0.6% +$9.91K 1.02% 41
2025
Q1
$1.83M Buy
5,883
+222
+4% +$65.6K 1.2% 17
2024
Q4
$1.48M Buy
5,661
+1,855
+49% +$550K 0.99% 49
2024
Q3
$1.23M Buy
+3,806
New +$1.24M 1.01% 24

Other funds holding AMGN

Nicholson Wealth Management Group's AMGN Position: Q2 2026 in Review

Nicholson Wealth Management Group reduced its Amgen (AMGN) stake by 2.2% in Q2 2026, selling an estimated $45.9K and leaving 5,858 shares worth $2.12M. The position accounts for 1.25% of the portfolio, ranked #26.

Nicholson Wealth Management Group first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nicholson Wealth Management Group held 5,858 shares of Amgen worth $2.12M as of Q2 2026.
  • Nicholson Wealth Management Group sold 134 Amgen shares in Q2 2026, an estimated $45.9K.
  • Amgen made up 1.25% of Nicholson Wealth Management Group's portfolio in Q2 2026, its #26 holding.
  • Nicholson Wealth Management Group first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nicholson Wealth Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.